Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
191 hedge funds and large institutions have $4.36B invested in Intercept Pharmaceuticals, Inc. in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 95 increasing their positions, 47 reducing their positions, and 34 closing their positions.
102% more repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 47
5% less funds holding
Funds holding: 200 → 191 (-9)
13% less capital invested
Capital invested by funds: $5.01B → $4.36B (-$646M)
15% less call options, than puts
Call options by funds: $115M | Put options by funds: $136M
21% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 34
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
+$179M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$43.2M |
| 3 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$30.4M |
| 4 |
CCI
Columbus Circle Investors
|
+$24.1M |
| 5 |
MAA
Managed Account Advisors
Jersey City,
New Jersey
|
+$21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$87.5M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$40.2M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$37.3M |
| 4 |
Jennison Associates
New York
|
-$32M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$31M |
ICPT Hedge Fund Activity: Q2 2015 in Review
191 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q2 2015, worth a combined $4.36B — down 13% from $5.01B a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of ICPT and 27 opened new positions — a net loss of 7 holders — while 47 trimmed existing stakes and 95 added.
The largest buyer was Ameriprise, adding an estimated $179M. The largest seller was Millennium Management, cutting an estimated $87.5M.
- 191 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q2 2015, down from 200 in Q1 2015.
- Funds reported $4.36B of Intercept Pharmaceuticals, Inc. stock for Q2 2015, down 13% quarter-over-quarter.
- 27 funds opened new Intercept Pharmaceuticals, Inc. positions in Q2 2015 and 34 closed out, a net change of -7 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q2 2015 was Ameriprise, an estimated $179M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q2 2015 was Millennium Management, an estimated $87.5M sold.
Based on aggregated 13F filings for Q2 2015.